32523534|t|Circumdatin D Exerts Neuroprotective Effects by Attenuating LPS-Induced Pro-Inflammatory Responses and Downregulating Acetylcholinesterase Activity In Vitro and In Vivo.
32523534|a|Alzheimer's disease (AD) is a prevalent neurodegenerative disorder with multifactorial causes, of which systemic inflammation may play a key role to promote neurodegeneration, and acetylcholinesterase (AChE) is a target protein to induce cholinergic transmission. Inhibitors toward inflammation and targeting AChE are regarded to promote cholinergic signaling of the central nervous system in AD therapy. During the search for neuroprotection agents from marine-derived compounds, seven circumdatin-type alkaloids from a coral-associated fungus Aspergillus ochraceus LZDX-32-15 showed potent inhibition against lipopolysaccharide (LPS)-induced nitric oxide (NO) production and activation of NF-kappaB report gene along with anti-AChE activities. Among the tested compounds, circumdatin D showed the most potent inhibitory effect against AChE activity and NO production. In vivo experiments using AD-like nematode models demonstrated that circumdatin D effectively delayed paralysis of CL4176 worms upon temperature up-shift via suppression of AChE activity and inflammatory-related gene expression. Moreover, circumdatin D interfered with inflammatory response by inhibiting the secretion of pro-inflammatory cytokines in LPS-induced BV-2 and primary microglia cells. Mechanistically, circumdatin D modulated Toll-like receptor 4 (TLR4)-mediated NF-kappaB, MAPKs and JAK/STAT inflammatory pathways in LPS-stimulated BV-2 cells, and protected primary neurons cells from LPS-induced neurotoxicity. Thus, circumdatin D is a potential agent for neuroprotective effects by the multi-target strategy.
32523534	60	63	LPS	Chemical	MESH:D008070
32523534	76	88	Inflammatory	Disease	MESH:D007249
32523534	118	138	Acetylcholinesterase	Gene	11423
32523534	170	189	Alzheimer's disease	Disease	MESH:D000544
32523534	191	193	AD	Disease	MESH:D000544
32523534	210	236	neurodegenerative disorder	Disease	MESH:D019636
32523534	283	295	inflammation	Disease	MESH:D007249
32523534	327	344	neurodegeneration	Disease	MESH:D019636
32523534	350	370	acetylcholinesterase	Gene	11423
32523534	372	376	AChE	Gene	11423
32523534	452	464	inflammation	Disease	MESH:D007249
32523534	479	483	AChE	Gene	11423
32523534	563	565	AD	Disease	MESH:D000544
32523534	657	683	circumdatin-type alkaloids	Chemical	-
32523534	715	747	Aspergillus ochraceus LZDX-32-15	Species	
32523534	781	799	lipopolysaccharide	Chemical	MESH:D008070
32523534	801	804	LPS	Chemical	MESH:D008070
32523534	814	826	nitric oxide	Chemical	MESH:D009569
32523534	861	870	NF-kappaB	Gene	18033
32523534	899	903	AChE	Gene	11423
32523534	944	957	circumdatin D	Chemical	-
32523534	1007	1011	AChE	Gene	11423
32523534	1066	1068	AD	Disease	MESH:D000544
32523534	1108	1121	circumdatin D	Chemical	-
32523534	1142	1151	paralysis	Disease	MESH:D010243
32523534	1155	1161	CL4176	CellLine	CVCL:3872
32523534	1162	1167	worms	Species	
32523534	1213	1217	AChE	Gene	11423
32523534	1231	1243	inflammatory	Disease	MESH:D007249
32523534	1279	1292	circumdatin D	Chemical	-
32523534	1309	1321	inflammatory	Disease	MESH:D007249
32523534	1366	1388	inflammatory cytokines	Disease	MESH:D000080424
32523534	1392	1395	LPS	Chemical	MESH:D008070
32523534	1404	1408	BV-2	CellLine	CVCL:0182
32523534	1455	1468	circumdatin D	Chemical	-
32523534	1479	1499	Toll-like receptor 4	Gene	21898
32523534	1501	1505	TLR4	Gene	21898
32523534	1516	1525	NF-kappaB	Gene	18033
32523534	1546	1558	inflammatory	Disease	MESH:D007249
32523534	1571	1574	LPS	Chemical	MESH:D008070
32523534	1586	1590	BV-2	CellLine	CVCL:0182
32523534	1639	1642	LPS	Chemical	MESH:D008070
32523534	1651	1664	neurotoxicity	Disease	MESH:D020258
32523534	1672	1685	circumdatin D	Chemical	-
32523534	Positive_Correlation	MESH:D008070	MESH:D020258
32523534	Association	MESH:D010243	11423
32523534	Association	MESH:D008070	21898
32523534	Positive_Correlation	MESH:D008070	MESH:D009569
32523534	Positive_Correlation	MESH:D008070	MESH:D007249

